NCT00295243View on ClinicalTrials.gov

Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

November 30, 2006

Conditions
Advanced Solid Malignancies
Interventions
DRUG

Topotecan

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Mayo Clinic

OTHER